TIMP1, tissue inhibitor of metalloproteinase-1, plays an important role in balancing the TIMP1/MMPs ratios [3, 7] which may represent potential biomarkers for predicting the clinical morbidity of diabetic foot ulceration patients as well [5]. This evidence concerns the gene TIMP1 and diabetic foot.